Trial Profile
A randomised phase II trial of reduced dosing regimen of cisplatin + brostallicin in advanced breast cancer patients
Status:
Planning
Phase of Trial:
Phase II
Latest Information Update: 13 Jun 2013
Price :
$35
*
At a glance
- Drugs Brostallicin (Primary) ; Cisplatin
- Indications Advanced breast cancer; Triple negative breast cancer
- Focus Therapeutic Use
- 13 Jun 2013 New trial record